Nicole M. Kuderer, MD | Authors

8002 LINCOLN DR W

Articles

CYP2D6 Testing in Breast Cancer: Ready for Prime Time?

December 16, 2009

This article will review and summarize the current data regarding the influence of the major cytochrome P450 2D6 (CYP2D6) genotypes and CYP2D6 inhibitors on tamoxifen metabolism and clinical efficacy. We will discuss the clinical relevance and limitations of this data and how to best incorporate our current understanding of CYP2D6 genotyping into our clinical practice and discussions with patients.